Degradation products of the extracellular pathogen Streptococcus pneumoniae access the cytosol via its pore-forming toxin

mBio

Volumn 6, Issue 1, 2015, Pages

  Lemon, Jamie K ^a   Weiser, Jeffrey N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BACTERIAL POLYSACCHARIDE; BAFILOMYCIN A1; CATHEPSIN B; CYTOCHALASIN D; GENTAMICIN; LACTATE DEHYDROGENASE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; LYSOZYME; MITOGEN ACTIVATED PROTEIN KINASE P38; PNEUMOLYSIN; TOLL LIKE RECEPTOR 4; BACTERIAL PROTEIN; BACTERIAL TOXIN; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; STREPTOLYSIN;

ACIDIFICATION; ANIMAL CELL; ARTICLE; BACTERIAL CAPSULE; BACTERIAL CELL WALL; BACTERIAL CLEARANCE; BACTERIAL STRAIN; BONE MARROW DERIVED MACROPHAGE; CELL DEATH; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; ELECTRON MICROSCOPY; ENZYME ACTIVATION; EXTRACELLULAR SPACE; HOST CELL; HOST PATHOGEN INTERACTION; HOST RESISTANCE; INNATE IMMUNITY; INTRACELLULAR KILLING; MICROBIAL DEGRADATION; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; STREPTOCOCCUS PNEUMONIAE; WILD TYPE; ANIMAL; C57BL MOUSE; ENZYMOLOGY; HUMAN; IMMUNOLOGY; MACROPHAGE; METABOLISM; MICROBIOLOGY; PNEUMOCOCCAL INFECTION;

BACTERIA (MICROORGANISMS); MURINAE; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CYTOSOL; HUMANS; MACROPHAGES; MICE; MICE, INBRED C57BL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 84924173423     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02110-14     Document Type: Article

References (39)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, the Hib and Pneumococcal Global Burden of Disease Study Team. 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902. http://dx. doi. org/10. 1016/S0140-6736(09)61204-6.
2. Bogaert D, de Groot R, Hermans PW. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4: 144-154. http://dx. doi. org/10. 1016/S1473-3099(04)00938-7.
3. McCool TL, Cate TR, Moy G, Weiser JN. 2002. The immune response to pneumococcal proteins during experimental human carriage. J Exp Med 195: 359-365. http://dx. doi. org/10. 1084/jem. 20011576.
4. Zhang Z, Clarke TB, Weiser JN. 2009. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119: 1899-1909. http://dx. doi. org/10. 1172/JCI36731.
5. Knapp S, Leemans JC, Florquin S, Branger J, Maris NA, Pater J, van Rooijen N, van der Poll T. 2003. Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med 167: 171-179. http://dx. doi. org/10. 1164/rccm. 200207-698OC.
6. Davis KM, Nakamura S, Weiser JN. 2011. Nod2 sensing of lysozymedigested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice. J Clin Invest 121: 3666-3676. http://dx. doi. org/10. 1172/JCI57761.
7. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278: 8869-8872. http://dx. doi. org/10. 1074/jbc. C200651200.
8. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276: 4812-4818. http://dx. doi. org/10. 1074/jbc. M008072200.
9. Tanabe T, Chamaillard M, Ogura Y, Zhu L, Qiu S, Masumoto J, Ghosh P, Moran A, Predergast MM, Tromp G, Williams CJ, Inohara N, Núñez G. 2004. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J 23: 1587-1597. http://dx. doi. org/10. 1038/sj. emboj. 7600175.
10. Korchev YE, Bashford CL, Pederzolli C, Pasternak CA, Morgan PJ, Andrew PW, Mitchell TJ. 1998. A conserved tryptophan in pneumolysin is a determinant of the characteristics of channels formed by pneumolysin in cells and planar lipid bilayers. Biochem J 329: 571-577.
11. Walker JA, Allen RL, Falmagne P, Johnson MK, Boulnois GJ. 1987. Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect Immun 55: 1184-1189.
12. Davis KM, Akinbi HT, Standish AJ, Weiser JN. 2008. Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae. PLoS Pathog. 4: e1000241. http://dx. doi. org/10. 1371/journal. ppat. 1000241.
13. Ratner AJ, Aguilar JL, Shchepetov M, Lysenko ES, Weiser JN. 2007. Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria. Cell Microbiol 9: 1343-1351. http://dx. doi. org/10. 1111/j. 1462-5822. 2006. 00878. x.
14. Sørensen UB, Henrichsen J, Chen HC, Szu SC. 1990. Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. Microb Pathog 8: 325-334. http://dx. doi. org/10. 1016/0882-4010(90)90091-4.
15. Farrand AJ, LaChapelle S, Hotze EM, Johnson AE, Tweten RK. 2010. Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface. Proc Natl Acad Sci U S A 107: 4341-4346. http://dx. doi. org/10. 1073/pnas. 0911581107.
16. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, Kurt-Jones E, Paton JC, Wessels MR, Golenbock DT. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci U S A 100: 1966-1971. http://dx. doi. org/10. 1073/pnas. 0435928100.
17. Nagahama M, Shibutani M, Seike S, Yonezaki M, Takagishi T, Oda M, Kobayashi K, Sakurai J. 2013. The p38 MAPK and JNK pathways protect host cells against Clostridium perfringens beta-toxin. Infect Immun 81: 3703-3708. http://dx. doi. org/10. 1128/IAI. 00579-13.
18. Huffman DL, Abrami L, Sasik R, Corbeil J, van der Goot FG, Aroian RV. 2004. Mitogen-activated protein kinase pathways defend against bacterial pore-forming toxins. Proc Natl Acad Sci U S A 101: 10995-11000. http://dx. doi. org/10. 1073/pnas. 0404073101.
19. Husmann M, Dersch K, Bobkiewicz W, Beckmann E, Veerachato G, Bhakdi S. 2006. Differential role of p38 mitogen activated protein kinase for cellular recovery from attack by pore-forming S. aureus alpha-toxin or streptolysin O. Biochem Biophys Res Commun 344: 1128-1134. http://dx. doi. org/10. 1016/j. bbrc. 2006. 03. 241.
20. Ratner AJ, Hippe KR, Aguilar JL, Bender MH, Nelson AL, Weiser JN. 2006. Epithelial cells are sensitive detectors of bacterial pore-forming toxins. J Biol Chem 281: 12994-12998. http://dx. doi. org/10. 1074/jbc. M511431200.
21. Das R, LaRose MI, Hergott CB, Leng L, Bucala R, Weiser JN. 2014. Macrophage migration inhibitory factor promotes clearance of pneumococcal colonization. J Immunol 193: 764-772. http://dx. doi. org/10. 4049/jimmunol. 1400133.
22. Tweten RK. 2005. Cholesterol-dependent cytolysins, a family of versatile pore-forming toxins. Infect Immun 73: 6199-6209. http://dx. doi. org/10. 1128/IAI. 73. 10. 6199-6209. 2005.
23. Madden JC, Ruiz N, Caparon M. 2001. Cytolysin-mediated translocation (CMT): a functional equivalent of type III secretion in Gram-positive bacteria. Cell 104: 143-152. http://dx. doi. org/10. 1016/S0092-8674(01)00198-2.
24. Portnoy DA, Jacks PS, Hinrichs DJ. 1988. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med 167: 1459-1471. http://dx. doi. org/10. 1084/jem. 167. 4. 1459.
25. Hruz P, Zinkernagel AS, Jenikova G, Botwin GJ, Hugot J-P, Karin M, Nizet V, Eckmann L. 2009. NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Proc Natl Acad Sci U S A 106: 12873-12878. http://dx. doi. org/10. 1073/pnas. 0904958106.
26. Bewley MA, Naughton M, Preston J, Mitchell A, Holmes A, Marriott HM, Read RC, Mitchell TJ, Whyte MK, Dockrell DH. 2014. Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation. mBio 5(5): e01710-14. http://dx. doi. org/10. 1128/mBio. 01710-14.
27. Cole AM, Liao H-I, Stuchlik O, Tilan J, Pohl J, Ganz T. 2002. Cationic polypeptides are required for antibacterial activity of human airway fluid. J Immunol 169: 6985-6991. http://dx. doi. org/10. 4049/jimmunol. 169. 12. 6985.
28. Faust N, Varas F, Kelly LM, Heck S, Graf T. 2000. Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood 96: 719-726.
29. Rae CS, Geissler A, Adamson PC, Portnoy DA. 2011. Mutations of the Listeria monocytogenes peptidoglycan N-deacetylase and O-acetylase result in enhanced lysozyme sensitivity, bacteriolysis, and hyperinduction of innate immune pathways. Infect Immun 79: 3596-3606. http://dx. doi. org/10. 1128/IAI. 00077-11.
30. Carrasco-Marín E, Madrazo-Toca F, de los Toyos JR, Cacho-Alonso E, Tobes R, Pareja E, Paradela A, Albar JP, Chen W, Gomez-Lopez MT, Alvarez-Dominguez C. 2009. The innate immunity role of cathepsin-D is linked to Trp-491 and Trp-492 residues of listeriolysin O. Mol Microbiol 72: 668-682. http://dx. doi. org/10. 1111/j. 1365-2958. 2009. 06673. x.
31. Parker D, Martin FJ, Soong G, Harfenist BS, Aguilar JL, Ratner AJ, Fitzgerald KA, Schindler C, Prince A. 2011. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. mBio 2(3): e00016-11. http://dx. doi. org/10. 1128/mBio. 00016-11.
32. Fang R, Tsuchiya K, Kawamura I, Shen Y, Hara H, Sakai S, Yamamoto T, Fernandes-Alnemri T, Yang R, Hernandez-Cuellar E, Dewamitta SR, Xu Y, Qu H, Alnemri ES, Mitsuyama M. 2011. Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection. J Immunol 187: 4890-4899. http://dx. doi. org/10. 4049/jimmunol. 1100381.
33. Witzenrath M, Pache F, Lorenz D, Koppe U, Gutbier B, Tabeling C, Reppe K, Meixenberger K, Dorhoi A, Ma J, Holmes A, Trendelenburg G, Heimesaat MM, Bereswill S, van der Linden M, Tschopp J, Mitchell TJ, Suttorp N, Opitz B. 2011. The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol 187: 434-440. http://dx. doi. org/10. 4049/jimmunol. 1003143.
34. Gupta R, Ghosh S, Monks B, Deoliveira RB, Tzeng TC, Kalantari P, Nandy A, Bhattacharjee B, Chan J, Ferreira F, Rathinam V, Sharma S, Lien E, Silverman N, Fitzgerald K, Firon A, Trieu-Cuot P, Henneke P, Golenbock DT. 2014. RNA and hemolysin of group B streptococcus induce IL-1+ by activating NLRP3 inflammasomes in mouse macrophages. J Biol Chem 289: 13701-13705. http://dx. doi. org/10. 1074/jbc. C114. 548982.
35. Kafka D, Ling E, Feldman G, Benharroch D, Voronov E, Givon-Lavi N, Iwakura Y, Dagan R, Apte RN, Mizrachi-Nebenzahl Y. 2008. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection. Int Immunol 20: 1139-1146. http://dx. doi. org/10. 1093/intimm/dxn071.
36. Vance RE, Isberg RR, Portnoy DA. 2009. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 6: 10-21. http://dx. doi. org/10. 1016/j. chom. 2009. 06. 007.
37. Matthias KA, Roche AM, Standish AJ, Shchepetov M, Weiser JN. 2008. Neutrophil-toxin interactions promote antigen delivery and mucosal clearance of Streptococcus pneumoniae. J Immunol 180: 6246-6254. http://dx. doi. org/10. 4049/jimmunol. 180. 9. 6246.
38. Sung CK, Li H, Claverys JP, Morrison DA. 2001. An rpsL cassette, Janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl Environ Microbiol 67: 5190-5196. http://dx. doi. org/10. 1128/AEM. 67. 11. 5190-5196. 2001.
39. Darrieux M, Moreno AT, Ferreira DM, Pimenta FC, de Andrade AL, Lopes AP, Leite LC, Miyaji EN. 2008. Recognition of pneumococcal isolates by antisera raised against PspA fragments from different clades. J Med Microbiol 57: 273-278. http://dx. doi. org/10. 1099/jmm. 0. 47661-0.